Celltrion Files Phase 4 IND with FDA to Support 240 mg High-Dose Zymfentra Regimen in US
Celltrion has submitted an Investigational New Drug application to the U.S. Food and Drug Administration for a Phase 4 clinical trial of Zymfentra...
Search results for "U.S. clinical trial"
The "Complete Protein" Myth: How Animal Meat Triggers Cancer, Hypertension, and Diabetes
Animal protein is widely celebrated as a "complete protein" because it contains all essential amino acids.
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon
During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
Robot-Assisted Operations Account for 1 in 5 Stomach Cancer Surgeries at Samsung Medical Center as Milestone Hits 1,500
Samsung Medical Center has performed more than 1,500 robot-assisted stomach cancer surgeries, reaching the milestone 16...
Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits
Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct...
Stopping Beta-Blockers After Heart Attack Safe for Stable Patients, Korea-France Study Finds
One medication many patients take long-term following a heart attack is a beta-blocker.
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51
Celltrion announced on August 24 that it has submitted a marketing authorization application to South Korea’s Ministry...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
Taking Leqembi Isn’t Enough: Only 3% of Early Alzheimer’s Patients Follow Recommended Lifestyle Habits
The arrival of disease-modifying treatments capable of slowing Alzheimer’s progression has offered patients newfound...
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are...